HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 21 to 32 of 32
< previous 
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleDong, Peixin; Xiong, Ying; Yue, Junming; Hanley, Sharon J. B.; Watari, HidemichiB7H3 As a Promoter of Metastasis and Promising Therapeutic Target-Frontiers in Oncology-6-Jul-2018
articleDong, Peixin; Xiong, Ying; Yue, Junming; Hanley, Sharon J.B; Watari, HidemichimiR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation-Oncotarget-1-May-2018
articleZhang, Tao; Zhao, Guannan; Yang, Chuanhe; Dong, Peixin; Watari, Hidemichi; Zeng, Lin; Pfeffer, Lawrence M.; Yue, JunmingLentiviral vector mediated-ASAP1 expression promotes epithelial to mesenchymal transition in ovarian cancer cells-Oncology Letters-Apr-2018
articleJi, Liang; Zhao, Guannan; Zhang, Peng; Huo, Wenying; Dong, Peixin; Watari, Hidemichi; Jia, Limin; Pfeffer, Lawrence M; Yue, Junming; Zheng, JinhuaKnockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells-Journal of Cancer-2018
articleZhao, Guannan; Wang, Qinghui; Gu, Qingqing; Qiang, Wenan; Wei, Jian-Jun; Dong, Peixin; Watari, Hidemichi; Li, Wei; Yue, JunmingLentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells-Oncotarget-7-Nov-2017
articleDong, Peixin; Xiong, Ying; Hanley, Sharon J. B.; Yue, Junming; Watari, HidemichiMusashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation-Journal of Experimental & Clinical Cancer Research-26-Oct-2017
articleXiong, Ying; Sun, Fei; Dong, Peixin; Watari, Hidemichi; Yue, Junming; Yu, Min-fei; Lan, Chun-yan; Wang, Yin; Ma, Ze-biaoiASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling-Journal of Experimental & Clinical Cancer Research-11-Apr-2017
articleHuo, Wenying; Zhao, Guannan; Yin, Jinggang; Ouyang, Xuan; Wang, Yinan; Yang, Chuanhe; Wang, Baojing; Dong, Peixin; Wang, Zhixiang; Watari, Hidemichi; Chaum, Edward; Pfeffer, Lawrence M.; Yue, JunmingLentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells-Journal of Cancer-2017
articleDong, Peixin; Xiong, Ying; Watari, Hidemichi; Hanley, Sharon JB; Konno, Yosuke; Ihira, Kei; Suzuki, Fumihiko; Yamada, Takahiro; Kudo, Masataka; Yue, Junming; Sakuragi, NoriakiSuppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124-Scientific Reports-21-Oct-2016
articleDong, Peixin; Xiong, Ying; Watari, Hidemichi; Hanley, Sharon J. B.; Konno, Yosuke; Ihira, Kei; Yamada, Takahiro; Kudo, Masataka; Yue, Junming; Sakuragi, NoriakiMiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells-Journal of Experimental & Clinical Cancer Research-5-Sep-2016
articleDong, Peixin; Ihira, Kei; Xiong, Ying; Watari, Hidemichi; Hanley, Sharon J.B.; Yamada, Takahiro; Hosaka, Masayoshi; Kudo, Masataka; Yue, Junming; Sakuragi, NoriakiReactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression-Oncotarget-12-Apr-2016
articleYue, Junming; Du, Ziyun; Zhou, Fu-Ming; Dong, Peixin; Pfeffer, Lawrence MApplications of CRSIPR/Cas9 in Cancer Research-Cancer Medicine & Anti Cancer Drugs-Mar-2016
Showing results 21 to 32 of 32
< previous 

 

Hokkaido University